Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-25 @ 1:46 AM
NCT ID:
NCT06448494
Eligibility Criteria:
Inclusion Criteria:
* Male or female subject, aged ≥ 75 years,
* Subject receiving or having received one of the 9 procedures targeted by the study: colectomy, or cholecystectomy, or nephrectomy, or transurethral resection of prostate adenoma, or transurethral prostatectomy, or transurethral or transcutaneous surgery for non-lithiasis conditions, or kidney and ureter surgery and major bladder surgery for tumor disease, or esophageal, stomach and duodenal surgery for malignancy, or transurethral resection of bladder,
* Subject orally agreeing (non-opposition), after having been informed and having been given a reasonable period of reflection, to participate in the study.
Exclusion Criteria:
* Patient having to undergo, at the time the study is proposed and over the theoretical period of participation, one or more other interventions already scheduled (other than the 9 mentioned in the inclusion criteria), and which, in the investigator's opinion, could have an impact on the study indicators7
* Subject unable to understand the purpose of the research, to answer questions and to give his/her decision to participate in the study,
* Subjects under legal protection or unable to express their consent, in accordance with article L1121-8 of the French Public Health Code,
* Subject already included in another research project involving the human body,
* Subject not affiliated to or not benefiting from a social security scheme.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
75 Years
Study:
NCT06448494
Study Brief:
Protocol Section:
NCT06448494